about us - S C HEALTHTECH CO., LTD.

OVERVIEW

Recognising key challenges impeding the advancement of the aquaculture industry, particularly in the realm of aquatic animal farming and export, coupled with the limited understanding of vaccines for aquatic organisms—a relatively novel concept in Thai society—SC HealthTech Company Limited has been established. Comprising experts in the intricate domains of treatment, knowledge aggregation, and technology integration within molecular biology, the company is dedicated to designing and producing vaccines for the diagnosis, classification, and treatment of diseases in aquatic animals.

Beginning with a comprehensive analysis encompassing diagnosis, classification, determination of infection type, assessment of severity, and evaluation of disease-causing potential, SC HealthTech utilizes its distinctive knowledge and technology to identify strains. These strains are subsequently employed in the creation of the most efficacious vaccines, considering both their functional attributes and structural formulations. The development process is conducted under the guidance of expert veterinarians to ensure suitability for use, emphasising safety and efficiency.

The resultant vaccines, characterised by their superior quality, efficiency, and competitive pricing, serve as viable alternatives to prolonged antibiotic use, thereby mitigating concerns related to residue accumulation. This is crucial for maintaining the integrity of business operations and exports. Additionally, the company pioneers the production of disease testing kits, offering a simplified and cost-effective alternative to traditional testing methods. These kits contribute significantly to alleviating the burden on farmers, aquaculture professionals, and aquatic animal business operators—both large and small—supporting a comprehensive approach to disease management and export facilitation.

SC Healthtech

aBOUT US

Vision

Facilitate and enhance the progression of the aquaculture industry, specifically within the realm of the sale and export of aquatic products. Employ advanced microbiological methodologies for the identification and classification of pathogens, concurrently engaging in the development of vaccines and associated products. Our focal point revolves around achieving comprehensive coverage, ensuring a meticulous and efficient outreach to all user groups involved in the aquaculture sector.

MISSION

Leveraging advanced molecular biology technology in conjunction with the expertise and proficiency of veterinary professionals, we aim to strategically address critical challenges inherent in the aquaculture business.

Core Value

1.

Microbiological technology and techniques in molecular biology aid in the segregation, categorization, and precise identification of different strains of microorganisms.

2.

The vaccine design employs an innovative method that merges immune-stimulating components from different pathogens to synthesize new proteins, potentially effectively preventing many diseases in the future.

3.

Manufacture beneficial microorganisms that help control shrimp diseases as a substitute for antibiotics. These can be produced in small amounts (3-5 liters), suitable for application in small farms.

4.

Provide standard, highly accurate kits for infection testing and residue detection, providing rapid and cost-effective results.

Establishment of S C healthtech Co., Ltd.

Launching of autogenous vaccine Product name: VAXSTREP-KU1; VAXSTREP-KU2

Award: MULTIVAC-STREP

Launching of the service for bacterial isolation and identification Launching E-commerce store

Launching of UNISC SA Detection Kit Launching of UNISC Nitrofurans Detection Kit Launching of the platform service for vaccine development

Launching of ORAVAX-STREP Establishing partnership with the private company

Excellence

Team

Our collaborative consortium comprises not only distinguished researchers specializing in the rarefied domain of advanced molecular biology techniques—uncommon in Thailand—but also expert consultants in veterinary science. This ensemble strategically determines the precise type and dosage of medicines, ensuring adherence to safety protocols and fostering sustainable progress.